IBBR awarded NIH grant to investigate T cell biology toward development of biotherapeutics
Published 1/31/19 by IBBR Findings may show how immune checkpoint LAG3 can be exploited to fight disease ROCKVILLE, Md., Jan. 31, 2019 /PRNewswire/ — A team of investigators from the Institute for Bioscience and Biotechnology Research (IBBR) and the University of Pittsburgh recently received a $3.6M National Institutes of …
